The latest market research report “Global Protein Therapeutics Market Analysis” by RNCOS provides an exhaustive view on the global protein therapeutics industry, examining and giving a detailed analysis of the various protein therapeutics used for disease prevention. The report discusses various aspects of the Protein Therapeutic Market, such as market size, area of applications and key geographical markets along with the drivers and restraints affecting the growth of each segment.
The Protein Therapeutic Market was valued in excess of US$ 57 Billion in 2006 and according to projections, it would grow at a CAGR 12.83% till 2010. The market is presently dominated by Monoclonal Antibodies and with double-digit growth projected for future, the segment is expected to bolster its dominant position. Insulin, Interferon Beta, G-CSF and coagulation factors are also exhibiting double-digit growth rates.
One of the biggest opportunity areas in the Protein Therapeutics Market will be in the field of Biogenerics, which is expected to create a multi-billion dollar market in future.
Key Findings
- US is the largest market for therapeutic proteins in the world followed by Europe and Japan.
- Insurance reimbursement is a major factor that decides the success of protein therapeutics.
- Growth in protein therapeutic market will create new opportunities for the drug discovery
Contract Research Organizations (CROs).
- High expenditure on R&D and high rate of failure in phase-3 clinical trials remains a major
challenge for the global protein therapeutics market.
- Until recently, protein therapeutics faced little generic threat; however, this is likely to change
in future with regulatory pathways for the approval of generics already present in Europe and
Asia and to be introduced in US by 2009.
Key Issues and Facts Analyzed
- Evaluation of past, current and future market trends.
- Discussion about the major protein therapeutics and their markets.
- Analysis of key geographical markets.
- Analysis of various challenges and opportunities for the industry.
- Future prospects of the various protein therapeutics segments.
- Profile discussion of key players in this sector.
Key Players Analyzed
This section provides the overview, key facts, and financial information of prominent players in the global protein therapeutics market, such as Amgen, Genentech, Roche Group, Merck Serono S.A, Johnson & Johnson, Novo Nordisk A/S etc.
Research Methodology Used
Information Sources
Information has been sourced from credible sources including books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.
Analysis Methods
The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.
For the purpose of this report, the following segments have been included in the Protein Therapeutics Market:
Monoclonal antibodies, EPO, Interferon’s, Blood Clotting Factors, HGH, FSH, G-CSF and Insulin
The following currency conversion has been followed in the report:
1 US$ = Euros 0.73, JPY 121
